APA (7th ed.) Citation

Zhao, Y., Niu, X., Zhang, Y., Zhao, L., Zhang, L., He, J., . . . Wang, R. Impact of supplementing Limosilactobacillus fermentum MN–LF23 on the eradication of Helicobacter pylori with 14–day standard quadruple therapy: A randomized, double–blind, placebo–controlled trial. BMC.

Chicago Style (17th ed.) Citation

Zhao, Yuyang, et al. Impact of Supplementing Limosilactobacillus Fermentum MN–LF23 on the Eradication of Helicobacter Pylori with 14–day Standard Quadruple Therapy: A Randomized, Double–blind, Placebo–controlled Trial. BMC.

MLA (9th ed.) Citation

Zhao, Yuyang, et al. Impact of Supplementing Limosilactobacillus Fermentum MN–LF23 on the Eradication of Helicobacter Pylori with 14–day Standard Quadruple Therapy: A Randomized, Double–blind, Placebo–controlled Trial. BMC.